As healthcare systems worldwide grapple with mounting challenges, France is quietly spearheading a race for AI-powered solutions. Recent Dealroom data reveals that French startups have secured $2.9 billion in healthtech funding in 2024, contributing to the European Union’s total investment of $19.6 billion. Here are the top-funded healthcare AI companies in Europe:
Caresyntax
Founders: Dennis Kogan, Björn von Siemens
Founded year: 2013
Total funding: $299M
Born in Berlin’s innovative tech scene, Caresyntax is a healthcare technology startup specialising in surgical data analytics. The company’s AI technology has the potential to revolutionise surgical procedures, providing real-time decision support, pre-operative planning, and post-operative analysis, thereby significantly improving patient outcomes.
Caresyntax’s AI, which integrates data from various sources, offers actionable insights throughout the surgical workflow. The technology has been deployed in 2,800 operating rooms worldwide, supporting over 32,000 surgical teams and improving care for more than 3 million patients annually, demonstrating its global reach and impact.
In August 2024, the company raised $180 million in Series C funding at a valuation of $500 million. This round was backed by a diverse group of investors, including Symbiotic Capital, MTIP AG, BIONIQ Capital, PFM Health Sciences, Pictet Alternative Advisors, surgical.ai, BlackRock Innovation Capital, Aescuvest, Optum Ventures, Cure Capital, Relyens Group, Vesalius Biocapital, Lauxera Capital, Plug & Play Growth Fund, and ProAssurance Corp.
Sword Health
Founders: Virgílio Bento, Márcio Colunas
Founded year: 2015
Total funding: $382M
Sword Health is a Portuguese healthcare technology company specialising in digital physical therapy. Its AI-driven platform aims to provide accessible, high-quality, and personalised physical therapy sessions.
The company’s AI, the “AI Clinician,” guides patients through therapy exercises, monitors progress, offers real-time feedback, ensures consistent and effective treatment, and reduces the need for in-person visits.
Sword Health’s latest funding round occurred in June 2024. It raised $130 million from Khosla Ventures, bringing its valuation to $3 billion.
Sonio
Founders: Cécile Brosset, David Amouyal, Rémi Besson, Dagmar Nuber, and Deepak Prakash
Founded year: 2020
Total funding: $30.5M
Sonio, a Paris-based healthcare technology company, specialises in AI-driven solutions for prenatal ultrasound diagnostics. The company uses artificial intelligence to enhance the quality and efficiency of prenatal ultrasound exams. Its AI system, Sonio Detect, assists in real-time by detecting anatomical structures, verifying image quality, and ensuring all necessary views are captured during the exam.
In May 2024, Samsung Medison acquired Sonio for $92.7 million.
Bioptimus
Founders: Jean-Philippe Vert, PhD, Rodolphe Jenatton, PhD, Eric Durand, PhD, Felipe Llinares, PhD, and Zelda Mariet, PhD
Founded year: 2023
Total funding: $35M
Bioptimus, a Paris-based startup, is focused on developing AI foundation models for biology. Their aim to create universal AI models that drive scientific research and biotechnological innovation holds great promise for the future.
The company builds comprehensive foundation models integrating data across biological scales—from molecules to cells, tissues, and organisms. Their AI, H-optimus-0, uses quantum-inspired physics and machine learning to analyse vast datasets, enabling drug discovery, diagnostics, and precision medicine breakthroughs.
On February 20, 2024, Bioptimus raised $35 million in a seed funding round from Hummingbird Ventures, Bpifrance, Sofinnova Partners, Frst Capital, Cathay Innovation, NJF Capital, Owkin, and Top Harvest Capital. This funding will help further develop its AI foundation model and expand research capabilities.
Quantum Surgical
Founders: Fernand Badano, Bertin Nahum, Lucien Blondel, and Sophie Roca
Founded year: 2016
Total funding: $46.3M
Quantum Surgical, a French company specializing in medical robotics and AI, was co-founded by Bertin Nahum in 2017. The company focuses on developing advanced technologies for minimally invasive cancer treatments.
At the heart of Quantum Surgical’s innovation is their Epione® platform, which uses AI to perform percutaneous tumour ablations. Their AI system integrates data from various sources, providing real-time guidance and decision support during surgeries. As a result, it enhances precision and safety, proving particularly effective for treating tumours in the abdomen and lungs.
On March 27, 2024, Quantum Surgical secured its latest funding, raising $32.5 million in a conventional debt round from the European Investment Bank.
Aqemia
Founders: Maximilien Levesque and Emmanuelle Martiano
Founded year: 2019
Total funding: $130M
Aqemia is a Paris-based deep tech startup specialising in AI-driven drug discovery. It combines quantum-inspired physics with generative AI to accelerate the identification and optimisation of drug candidates. Aqemia’s AI generates data using quantum and statistical physics algorithms instead of relying on existing experimental data.
In January 2024, Aqemia secured an additional €30 million in funding from Elaia Partners, Bpifrance, Eurazeo, and Wendel, bringing their Series A total to €60 million.
Wandercraft
Founders: Nicholas Simon, Matthieu Masselin, and Jean-Louis Constanza
Founded year: 2012
Total funding: $66.9M
Wandercraft is a French company specialising in medical robotics. They’re best known for developing the Atalante exoskeleton, which helps people with mobility impairments stand and walk again.
Wandercraft uses AI to enhance the functionality of its exoskeletons. Their AI-driven system offers real-time adjustments and self-balancing capabilities, allowing hands-free walking. By integrating sensor data, the AI optimises walking patterns and ensures stability, making the exoskeletons more effective and user-friendly.
On April 4, 2024, Wandercraft secured its latest funding: a $27.16 million loan from the European Investment Bank.
Resilience
Founders: Rahul Singhvi, SC.D.
Founded year: 2021
Total funding: $74.5M
Resilience is a digital health platform focused on remote monitoring and personalised support for oncology patients. Through innovative digital solutions, it aims to improve cancer patients’ quality of life and treatment adherence.
The company leverages AI to enhance remote patient monitoring and support. Its AI-driven platform collects and analyses clinical, biological, and behavioural data to provide personalised care recommendations, detect complications early, optimise treatment plans, and ensure timely interventions.
Resilience’s latest Series B funding round raised $25 million in May 2024 from Seaya, Singular, Cathay Innovation, Picus Capital, and Red River West. This funding will help Resilience expand its AI capabilities and scale its platform to support more patients globally.
Nabla
Founders: Alexandre Lebrun, Delphine Groll, Martin Raison
Founded year: 2018
Total funding: $42.7M
Nabla is a healthcare technology company that improves clinical workflows through AI-driven solutions. Their main product, an AI assistant, helps medical professionals with clinical documentation and patient care. This assistant listens to doctor-patient conversations, transcribes them, and generates detailed medical reports.
Nabla’s latest funding round—a Series B that raised $24 million on January 5, 2024—was led by Cathay Innovation and ZEBOX Ventures. This investment aims to enhance Nabla’s AI capabilities and speed up its expansion into the US market.
Smart Reporting
Founders: Prof. Dr. Wieland Sommer
Founded year: 2014
Total funding: $54.8M
Smart Reporting is a Munich-based healthtech company specialising in medical reporting and documentation software, focusing on radiology and pathology.
The company leverages AI to boost the efficiency and accuracy of medical reporting. Its AI-driven platform, SmartReports, combines voice recognition and data analytics to streamline the reporting process. The company’s AI technology pre-populates reports, ensures compliance with medical guidelines, and offers real-time decision support, dramatically cutting down doctors’ time on paperwork.In April 2024, Smart Reporting secured €23 million in a Series C funding round from Bayern Kapital and TVM Capital Life Science. The company plans to use this investment to expand product development and forge international partnerships, focusing on North America and Australia.